RBC Capital raises target for Celanese stock to USD 46.00

Published on 10/15/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 17.76 percent sequentially to USD 2.75 billion. Celanese stock costs EUR 41.81 on October 15, 2026.

RBC target and quarterly figures

RBC Capital raised its Celanese target from USD 45.00 to USD 46.00 on October 13, 2026.
Second-quarter revenue increased 17.76 percent sequentially to USD 2.75 billion.
Celanese stock costs EUR 41.81 at Lang & Schwarz on October 15, 2026 at 10:18 p.m. CEST.
Celanese will release third-quarter results after the market close on November 2, 2026.

Luftaufnahme einer großen Spezialchemie-Produktionsanlage bei Sonnenuntergang in Irving Texas — Celanese Corp. Chemieanlagengelände in Irving Texas mit Destillationstürmen und Kühltürmen fotografiert US1510201049, Illustration mit AI erstellt.

RBC Capital raised its Celanese price target from USD 45.00 to USD 46.00 on October 13, 2026, while maintaining a Sector Perform rating, according to Markets Insider. The USD 46.00 target was 0.95 percent below the USD 46.44 NYSE quote at 4:00 p.m. ET on October 15, 2026. Celanese stock was trading at EUR 41.81 at Lang & Schwarz on October 15, 2026 at 10:18 p.m. CEST.

Revenue improved in the second quarter

Celanese reported USD 2.75 billion in revenue for the second quarter of 2026, up 17.76 percent from USD 2.34 billion in the first quarter. The company also reported USD 133.00 million in net earnings attributable to common shareholders and diluted earnings per share of USD 1.13 for the second quarter.

The operating margin was 10.00 percent in the second quarter, compared with 9.00 percent in the first quarter. Operating cash flow increased to USD 209.00 million from USD 76.00 million over the same comparison. These figures place the latest quarterly performance above the first-quarter base, but the sequential comparison does not by itself establish a full-year trend.

Price sits below the yearly high

The USD 46.44 NYSE quote on October 15, 2026 stood between Celanese's 52-week low of USD 35.13 and high of USD 70.70. The finance quote showed 1,169,993 shares traded against an average volume of 1,814,553 shares. The market capitalization was USD 5.1 billion.

Celanese had 2025 net sales of USD 9.5 billion, according to the company's investor information. Its portfolio covers specialty materials and chemical products used in automotive, medical, electronics, food, coatings and industrial applications.

November results set the next date

Celanese will distribute its third-quarter 2026 earnings release after the New York Stock Exchange closes on November 2, 2026, and will hold the related conference call on November 3, 2026, according to Celanese. The company scheduled the call for 10:00 a.m. ET. The next report will give investors a fresh test of whether the second-quarter revenue improvement carried into the September quarter.

Valuation and cash generation

The latest quarterly figures combine stronger revenue with positive operating cash flow, while the stock's USD 5.1 billion market capitalization remains tied to a business managing a substantial specialty-chemicals portfolio. RBC Capital's USD 46.00 target provides a dated market reference, but its Sector Perform rating signals a measured stance rather than a directional recommendation.

At Lang & Schwarz, Celanese stock was trading at EUR 41.81 on October 15, 2026 at 10:18 p.m. CEST. The quote is an intraday euro value for investors in Germany, while the USD figures above describe the NYSE listing separately. The further course of trading is shown by the continuously updated real-time quote of Celanese stock.